Skip to main content
OpenTrials
Completed

NCT Number: NCT04211194

Registry for Upper Gastrointestinal Bleeding

This project aims to evaluate the data on all patients undergoing endoscopic therapy for upper gastrointestinal bleeding.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Peptic Ulcer Hemorrhage Digestive System Diseases Duodenal Diseases Gastrointestinal Diseases Gastrointestinal Hemorrhage Hemorrhage Intestinal Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Peptic Ulcer Peptic Ulcer, Acute With Hemorrhage Stomach Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Center for Interventional Endoscopy

Orlando, Florida, 32803, United States

About this study

This project is being performed to evaluate the outcomes of patients undergoing endoscopic procedures for upper gastrointestinal bleeding at all AdventHealth hospitals in Central Florida. This information will enable quality control of patients undergoing treatment for upper gastrointestinal bleeding across all campuses in the AdventHealth system in Central Florida and hence improve the delivery ot care extended to the investigator's patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient is 18 years of age or greater
  • Patient is undergoing endoscopic treatment for upper gastrointestinal bleeding

Exclusion criteria

  • Under the age of 18
  • Patient not undergoing endoscopic treatment for upper gastrointestinal bleeding

Treatment and study plan

Upper GI Endoscopy

Procedure

Patients with upper gastrointestinal bleeding undergoing endoscopic therapy. Information regarding the need for interventional radiology procedures or surgical interventions will also be collected in patients in whom endoscopic therapy is not successful.

Primary outcomes

  1. Mortality Rate

    Time frame: 30 days

    Mortality rate from upper gastrointestinal bleeding and from any etiology

Secondary outcomes

  1. Rate of Reintervention

    Time frame: 30 days

    Need for repeat endoscopic treatment for upper gastrointestinal bleeding

  2. Rate of Recurrence

    Time frame: 30 days

    Recurrence of upper gastrointestinal bleeding following endoscopic treatment

  3. Rate of Readmission

    Time frame: 30 days

    Need for readmission to hospital for treatment of upper gastrointestinal bleeding

  4. Length of hospital stay

    Time frame: 30 days

    Length of hospitalization from index endoscopic procedure to discharge

  5. Costs

    Time frame: 30 days

    Total hospital costs from admission for upper gastrointestinal bleeding

  6. Treatment success

    Time frame: 30 days

    Successful treatment of upper gastrointestinal bleeding using endoscopic therapy as determined by a yes/no answer.

Sponsors and collaborators

Lead sponsor

AdventHealth

Other

Registry information

Official study title

The Orange County Bleeding Consortium (OCBC): Registry of Patients Undergoing Endoscopic Procedures for Upper Gastrointestinal Bleeding in AdventHealth Hospitals in Central Florida

Important dates

Study start
2019
Primary completion
2021
Study completion
2021
First posted
Dec 26, 2019
Registry last updated
Feb 17, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.